Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 …
SE Goldstone, AR Giuliano, JM Palefsky… - The Lancet Infectious …, 2022 - thelancet.com
Background The quadrivalent human papillomavirus (HPV) vaccine was shown to prevent
infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled …
infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled …
Trends in HPV-and non-HPV-associated vulvar cancer incidence, United States, 2001–2017
JM Mix, SV Gopalani, S Simko, M Saraiya - Preventive medicine, 2022 - Elsevier
Vulvar cancer incidence has been rising in recent years, possibly due to increasing
exposure to human papillomavirus (HPV). We assessed incidence rates of HPV-associated …
exposure to human papillomavirus (HPV). We assessed incidence rates of HPV-associated …
Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a …
F Inturrisi, L Rozendaal, NJ Veldhuijzen… - PLoS …, 2022 - journals.plos.org
Background Human papillomavirus (HPV)-based screening programs still use one-size-fits-
all protocols but efficiency and efficacy of programs may be improved by stratifying women …
all protocols but efficiency and efficacy of programs may be improved by stratifying women …
Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women
MT Bruno, N Cassaro, SG Vitale, A Guaita, S Boemi - Virology journal, 2022 - Springer
Background The aim of this study was to evaluate the regression rate of CIN2 p16 positive
lesions in women over 25 years of age and identify possible predictors of regression …
lesions in women over 25 years of age and identify possible predictors of regression …
Oral HPV infection among indigenous Australians; incidence, persistence, and clearance at 12-month follow-up
Background: Persistent oral human papillomavirus (HPV) infection is a risk factor for
oropharyngeal squamous cell carcinoma (OPSCC). Indigenous Australians have a higher …
oropharyngeal squamous cell carcinoma (OPSCC). Indigenous Australians have a higher …
Prevalence and genotype distribution of human papillomavirus infection among 40,613 women: an outpatient-based population study in Kunming, Yunnan
Y Zhang, Y Xu, Z Dian, G Zhang, X Fan… - Frontiers in Public …, 2022 - frontiersin.org
Human Papillomavirus (HPV) infection is one of the most common sexually transmitted
infections worldwide. The current study aimed to investigate the prevalence and genotype …
infections worldwide. The current study aimed to investigate the prevalence and genotype …
Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol
G Murenzi, F Shumbusho, N Hansen, A Munyaneza… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Prophylactic human papillomavirus (HPV) vaccines have been shown to be
highly effective in protecting women against cervical infections, high-grade abnormalities …
highly effective in protecting women against cervical infections, high-grade abnormalities …
[HTML][HTML] Protocol: Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol
G Murenzi, F Shumbusho, N Hansen, A Munyaneza… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Methods WLWH and HIV-negative women who likely did (birth cohorts 1996 and later) and
WLWH and HIV (−) negative who likely did not (birth cohorts before 1996) receive HPV …
WLWH and HIV (−) negative who likely did not (birth cohorts before 1996) receive HPV …
[HTML][HTML] HPV vaccination among seropositive, DNA negative cohorts: A systematic review & meta-analysis
C Mac Eochagain, R Power, I Parker… - Journal of Gynecologic …, 2022 - ncbi.nlm.nih.gov
Objective Vaccine efficacy among previously exposed, but currently uninfected women, ie,
those who have serological evidence of a prior human papillomavirus (HPV) infection …
those who have serological evidence of a prior human papillomavirus (HPV) infection …
Human papillomavirus bowel colonization in inflammatory bowel disease: A comparative case control study
MH Mosli, M Albeshri, MN Alsanea… - Journal of Family …, 2022 - journals.lww.com
Results: A total of 201 patients, including 104 patients with IBD and 97 non-IBD controls,
were prospectively included. Females comprised 55.5% of the study participants (58% vs …
were prospectively included. Females comprised 55.5% of the study participants (58% vs …